Physician profile
Suzanne Schaffer
NPI 1306945233
$1,319.76
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,161 · 2020: $159.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $155.60 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $152.84 | 2019-2020 | |
| Glaxosmithkline, LLC. | $150.99 | 2019-2020 | |
| Amarin Pharma, INC. | $126.60 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $120.15 | 2019 | |
| Novo Nordisk INC | $115.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $83.53 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $57.64 | 2019-2020 | |
| Astellas Pharma US INC | $50.70 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $37.90 | 2019 | |
| Lilly USA, LLC | $34.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $33.79 | 2019 | |
| Sanofi Pasteur INC. | $32.99 | 2019 | |
| Pfizer INC. | $24.50 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.31 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $22.72 | 2019 | |
| Abbvie INC. | $15.74 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.42 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.05 | 2019 | |
| Shire North American Group INC | $13.42 | 2019 | |
| Ironwood Pharmaceuticals, INC | $12.73 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.31 | 2020 | |
| Circassia INC. | $11.16 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.